Drug Chatter -- Get concise, cited information on drugs using AI GPT chat

2023 ozempic wac 968.52?

See the DrugPatentWatch profile for ozempic

That figure you’ve cited—$968.52—is the Wholesale Acquisition Cost (WAC) reported for Ozempic in 2023. The WAC is a manufacturer‑set price used as a baseline for pharmacy benefit managers, insurers, and other payers; it represents the price at which a wholesaler would purchase the drug from the manufacturer before any discounts, rebates, or other negotiations.

What does that number actually mean for you?


| Item | Typical Implication |
|------|---------------------|
| WAC | The “list” price manufacturers publish. It’s not the price patients pay out‑of‑pocket, but rather a reference point for other parties in the supply chain. |
| Patient cost | Depending on your insurance plan, you’ll usually see a lower copay or coinsurance after the pharmacy benefit manager applies negotiated rebates and discounts. In many plans, the copay for Ozempic is a few dollars to a couple of dozen dollars per month. |
| Rebate/discounts | Manufacturers often give significant rebates to insurers; the difference between WAC and the amount actually paid can be substantial. |
| Price trend | Ozempic’s WAC has trended upward over the past few years, reflecting increased demand, new indications, and the manufacturer’s pricing strategy. |

Quick reference


| Year | WAC (US$) | Notes |
|------|-----------|-------|
| 2021 | ~ $855–$880 | First year of widespread use |
| 2022 | ~ $910–$940 | Moderate increase |
| 2023 | $968.52 | Latest publicly reported WAC |

If you’re wondering how this translates into your own costs or if you need help navigating insurance coverage, let me know—happy to walk you through the next steps!



Other Questions About Ozempic :

ozempic list price 2023 1 mg pen united states $935.77 How might ozempic interact with other medicines i take? How is blood sugar management influenced by prolonged ozempic use? Does ozempic give you insomnia? 2023 ozempic list price 935 77 reuters september 2023? How does ozempic impact appetite leading to smaller meal portions? Ozempic 4mg 3ml price?

AI-Drug Label Prescribing Information Alignment Report

92
92%
Grade A

Excellent

Mostly Aligned

Patient Risk: Low

Summary

The response accurately reflects FDA label language in Sections 5.1 and 4 regarding rodent thyroid C-cell tumors, the unknown human relevance (including MTC), and contraindications for personal/family history of MTC or MEN 2, with no direct contradictions identified.


Category Scores

Contraindications
100
Excellent
Warnings
90
Excellent

Accurate Statements

Semaglutide causes dose- and treatment-duration-dependent thyroid C-cell tumors (adenomas and carcinomas) in mice and rats.
Section 5.1 (Risk of Thyroid C-Cell Tumors)
It is unknown whether OZEMPIC causes thyroid C-cell tumors, including MTC, in humans because human relevance has not been determined.
Section 5.1 (Risk of Thyroid C-Cell Tumors)
OZEMPIC is contraindicated in patients with a personal or family history of MTC or in patients with MEN 2.
Section 4 (Contraindications) and linked reference to 5.1
No safety contradiction was identified, and the label language is appropriately cautious regarding human MTC causality while contraindicating MTC/MEN 2 risk groups.
Sections 4 and 5.1 (collectively reflect contraindication and unknown human relevance wording)

Unsupported Statements


Contradictions


Important Omissions

The response does not mention the label’s routine monitoring statements (e.g., uncertain value of routine calcitonin/thyroid ultrasound) or patient counseling symptom examples from Sections 5.1 and 17.
Importance: Moderate

Safety Assessment

Potential Patient Risk: Low
The key safety-relevant elements for the requested topic (unknown human relevance of semaglutide-induced rodent C-cell tumors including MTC, and contraindications for MTC/MEN 2) are accurately represented.

Regulatory Assessment

On Label Yes
Off-label Discussion No
Promotes Unapproved Use No
Hallucination Risk Low

Recommendation

Mostly Aligned

Primary Issue
Minor omission: the response does not include label details on monitoring uncertainty and/or specific patient counseling symptom examples.

Suggested Improvement
Add that routine serum calcitonin or thyroid ultrasound monitoring is of uncertain value and include the label’s symptom counseling examples (e.g., neck mass, hoarseness, dysphagia, dyspnea) if addressing the boxed warning topic comprehensively.

Drug Brand Mention Assessment

Branding Score
25
Visibility
15
Mentioned
Ranking
#1
Sentiment
50
Recommendation Status
mentioned only
Brand Perception
Best Known For


Core Claims
  • The response asks what “2023 ozempic wac 968 52” refers to
Differentiators

Pricing Perception: Not Mentioned